HER2 Support Group Forums - Ipsogen Launches A New Test To Guide Hormonotherapy Prescription In Breast Cancer

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- Breast Cancer Newsfeed (https://her2support.org/vbulletin/forumdisplay.php?f=52)

- - Ipsogen Launches A New Test To Guide Hormonotherapy Prescription In Breast Cancer (https://her2support.org/vbulletin/showthread.php?t=39347)

News	05-08-2009 07:10 AM

Ipsogen Launches A New Test To Guide Hormonotherapy Prescription In Breast Cancer

Ipsogen SA (Alternext - FR0010626028 - ALIPS), a molecular diagnostic company specialized in the development, manufacturing and commercialization of diagnostic assays for breast cancer and leukemia, today announces the European launch of the MapQuant Dx(TM) HR test.

More...

All times are GMT -7. The time now is 09:17 AM.